BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Arcoxia® (etoricoxib): Altered dosage recommendations for patients with rheumatoid arthritis and ankylosing spondylitis (Bekhterev's disease)

Active substance: etoricoxib

The company MSD is circulating information on altered dosage recommendations for the medicinal product Arcoxia®.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 902KB, File is accessible

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK